158 related articles for article (PubMed ID: 31256738)
21. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
Else M; Dearden CE; Matutes E; Garcia-Talavera J; Rohatiner AZ; Johnson SA; O'Connor NT; Haynes A; Osuji N; Forconi F; Lauria F; Catovsky D
Br J Haematol; 2009 Jun; 145(6):733-40. PubMed ID: 19344416
[TBL] [Abstract][Full Text] [Related]
22. Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol.
Espinosa Lara P; Quirós Redondo V; Aguado Lobo M; Jiménez-Reyes J
Ann Hematol; 2017 Jul; 96(7):1209-1210. PubMed ID: 28391438
[No Abstract] [Full Text] [Related]
23. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
[TBL] [Abstract][Full Text] [Related]
24. Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant.
Imamura T; Ohtsuka E; Ogata M; Oka F; Kashima K; Kikuchi H; Nasu M
Int J Hematol; 2004 Dec; 80(5):432-4. PubMed ID: 15646655
[TBL] [Abstract][Full Text] [Related]
25. Chemoimmunotherapy for hairy cell leukemia.
Ravandi F
Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
[TBL] [Abstract][Full Text] [Related]
27. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
Dasanu CA; Alexandrescu DT
Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
[TBL] [Abstract][Full Text] [Related]
28. Low-dose cladribine for symptomatic hairy cell leukaemia.
Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
[TBL] [Abstract][Full Text] [Related]
29. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D
Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250
[TBL] [Abstract][Full Text] [Related]
30. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
31. Phase II clinical study of cladribine in the treatment of hairy cell leukemia.
Machii T; Chou T; Suzuki M; Ohe Y; Katagiri S; Kitano EK; Kitano K; Fujiyama Y; Izumi T; Shimazaki C; Nanba K; Ohashi Y; Kitani T;
Int J Hematol; 2005 Oct; 82(3):230-5. PubMed ID: 16207596
[TBL] [Abstract][Full Text] [Related]
32. The revolving door: antibiotic allergy labelling in a tertiary care centre.
Knezevic B; Sprigg D; Seet J; Trevenen M; Trubiano J; Smith W; Jeelall Y; Vale S; Loh R; McLean-Tooke A; Lucas M
Intern Med J; 2016 Nov; 46(11):1276-1283. PubMed ID: 27530619
[TBL] [Abstract][Full Text] [Related]
33. Wrist tuberculosis in cladribine--induced remission of hairy cell leukosis.
Panchovska MS; Solakov PT; Anavi BL; Spasov EA; Tokmakova KP
Folia Med (Plovdiv); 2000; 42(4):37-40. PubMed ID: 15359513
[TBL] [Abstract][Full Text] [Related]
34. Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel.
Inbar M; Herishanu Y; Goldschmidt N; Bairey O; Yuklea M; Shvidel L; Fineman R; Aviv A; Ruchlemer R; Braester A; Najib D; Rouvio O; Shaulov A; Greenbaum U; Polliack A; Tadmor T
Anticancer Res; 2018 Nov; 38(11):6423-6429. PubMed ID: 30396967
[TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature.
Hassan R; Gupta M; Kern W; Ozer H
Leuk Lymphoma; 2004 Oct; 45(10):2149-52. PubMed ID: 15370263
[TBL] [Abstract][Full Text] [Related]
36. Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
Forconi F; Toraldo F; Sozzi E; Amato T; Raspadori D; Lauria F
Leuk Lymphoma; 2007 Dec; 48(12):2441-3. PubMed ID: 18067021
[No Abstract] [Full Text] [Related]
37. Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia.
Park H; Youk J; Kim I; Yoon SS; Park S; Lee JO; Bang SM; Koh Y
Ann Hematol; 2016 Oct; 95(11):1777-86. PubMed ID: 27539617
[TBL] [Abstract][Full Text] [Related]
38. Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadenosine for hairy cell leukemia.
Ilyas W; Myers D; Mann R; Seraly MP
J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):316-8. PubMed ID: 10426918
[TBL] [Abstract][Full Text] [Related]
39. First-Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia-Free Survival.
Amhaz G; Ibrahim A; Usta U; El Cheikh J; Bazarbachi A; Abou Dalle I
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):564-566. PubMed ID: 33994319
[No Abstract] [Full Text] [Related]
40. [Treatment of hairy cell leukemia with cladribine].
Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
